[1]
“Efficacy of transcutaneous retrobulbar amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: A single-center retrospective observational study”., SJHR-Africa, vol. 6, no. 12, p. 8, Dec. 2025, doi: 10.51168/sjhrafrica.v7i3.2192.